International Clinical Trial: Absorbable Hemostatic Fluid Gelatin Trial

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830797) titled 'Absorbable Hemostatic Fluid Gelatin Trial' on Sept. 7.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).

Primary Sponsor: Medprin Regenerative Medical Technologies Co., Ltd.

Condition: Surgical Bleeding

Intervention: Device: Absorbable Hemostatic Fluid Gelatin

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: September 8, 2026

Target Sample Size: 324

To know more, visit https://clinicaltrials.gov/study/NCT07830797

Published by HT Digital Content Services with pe...